Exact Mass: 546.355635
Exact Mass Matches: 546.355635
Found 500 metabolites which its exact mass value is equals to given mass value 546.355635
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
UNC 0642
Dilauryl 3,3'-thiodipropionate
Dilauryl 3,3-thiodipropionate is a food and polymer antioxidant. Food and polymer antioxidant
endo-1,4-beta-Xylanase
endo-1,4-beta-Xylanase is used in baked goods and brewing to treat whole grain, grain mashes and doughs to reduce viscosity for processing. Hydrolyses 1,4-b-D-xylosidic linkages in xylans. It is used in baked goods and brewing to treat whole grain, grain mashes and doughs to reduce viscosity for processing. Hydrolyses 1,4-b-D-xylosidic linkages in xylans
Hovenidulcigenin B
Sapogenin from Hovenia dulcis (raisin tree). Sapogenin from Hovenia dulcis (raisin tree)
1-O,4-O-Bis[(2S)-2-ethylhexyl] 2-O-[(2R)-2-ethylhexyl] benzene-1,2,4-tricarboxylate
Anamorelin
3,5,6-Tris(2-ethylhexyl)benzene-1,2,4-tricarboxylic acid
2-(4,4-Difluoro-1-piperidinyl)-6-methoxy-N-[1-(1-methylethyl)-4-piperidinyl]-7-[3-(1-pyrrolidinyl)propoxy]-4-quinazolinamine
DG(10:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)
DG(10:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/10:0/0:0)
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))
DG(10:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/10:0)
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(10:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)
DG(10:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/10:0/0:0)
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))
DG(10:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/10:0)
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)
DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/10:0/0:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))
DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/10:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)
DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/10:0/0:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))
DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/10:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(10:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)
DG(10:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/10:0/0:0)
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))
DG(10:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/10:0)
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(10:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)
DG(10:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/10:0/0:0)
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))
DG(10:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/10:0)
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Dodecanoic acid ingenol ester
(3R)-7,8,3,4,7,8-Hexadehydro-beta,beta-caroten-3-ol
3-Benzoyl-(3beta,5alpha,11alpha)-3,11-Dihydroxystigmasta-7,20-dien-6-one|Physanol A
methyl (23E)-(20S)-20,25-dihydroxy-26-acetoxy-3,4-secodammara-4(28),23-dien-3-oate
7alpha-acetoxy-17alpha-20S-21,24-epoxy-apotirucall-14-en-3-one-23R,24S,25-triol
12-beta-acetoxycimigenol|12beta-acetoxycimigenol|12beta-O-acetylcimigenol
(24S)-5-hydroxy-24-methyl-5alpha-cholesta-7,22-dien-3beta-yl-D-xylopyranoside
(3beta,12beta,23S,24R,25S)-16,23:23,26-diepoxy-12-acetoxy-3,24,25-trihydroxy-9,19-cycloartane|yunnanterpene C
7alpha-acetoxy-21S?,23R?-epoxy-21beta,24S?,25-trihydroxy-4,4,8-trimethyl-cholesta-14-en-3-one|brujavanone K
3beta-acetoxy-2beta,19alpha,23-trihydroxyurs-12-en-28-oic acid|meyanthic acid
methyl (23E)-(12R,20S)-12-acetoxy-20,25-dihydroxy-3,4-secodammara-4(28),23-dien-3-oate
(22R,24xi,28xi)-5beta,6beta-epoxy-22,28-oxido-24-methyl-5alpha-cholestan-3beta,25,28-triol-3,28-diacetate
12-deacetoxypapyriferic acid|3-O-malonylepiocotillol II|3-O-malonylepiocotillol-II|3alpha-(carboxyacetoxy)-20(S),24(R)-epoxydammarane-25-ol
N-[5-[[4-[4-[acetyl(hydroxy)amino]butylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxybutanediamide
Phe Lys Pro Arg
Phe Lys Arg Pro
Phe Pro Lys Arg
Phe Pro Arg Lys
Phe Arg Lys Pro
Phe Arg Pro Lys
Ile Lys Met Arg
Ile Lys Arg Met
Ile Lys Thr Trp
Ile Lys Trp Thr
Ile Met Lys Arg
Ile Met Arg Lys
Ile Arg Lys Met
Ile Arg Met Lys
Ile Thr Lys Trp
Ile Thr Trp Lys
Lys Phe Pro Arg
Lys Phe Arg Pro
Lys Ile Met Arg
Lys Ile Arg Met
Lys Leu Met Arg
Lys Leu Arg Met
Lys Met Ile Arg
Lys Met Leu Arg
Lys Met Arg Ile
Lys Met Arg Leu
Lys Pro Phe Arg
Lys Pro Arg Phe
Lys Arg Phe Pro
Lys Arg Ile Met
Lys Arg Leu Met
Lys Arg Met Ile
Lys Arg Met Leu
Lys Arg Pro Phe
Leu Lys Met Arg
Leu Lys Arg Met
Leu Met Lys Arg
Leu Met Arg Lys
Leu Arg Lys Met
Leu Arg Met Lys
Met Ile Lys Arg
Met Ile Arg Lys
Met Lys Ile Arg
Met Lys Leu Arg
Met Lys Arg Ile
Met Lys Arg Leu
Met Leu Lys Arg
Met Leu Arg Lys
Met Arg Ile Lys
Met Arg Lys Ile
Met Arg Lys Leu
Met Arg Leu Lys
Pro Phe Lys Arg
Pro Phe Arg Lys
Pro Lys Phe Arg
Pro Lys Arg Phe
Pro Arg Phe Lys
Pro Arg Lys Phe
Arg Phe Lys Pro
Arg Phe Pro Lys
Arg Ile Lys Met
Arg Ile Met Lys
Arg Lys Phe Pro
Arg Lys Ile Met
Arg Lys Leu Met
Arg Lys Met Ile
Arg Lys Met Leu
Arg Lys Pro Phe
Arg Leu Lys Met
Arg Leu Met Lys
Arg Met Ile Lys
Arg Met Lys Ile
Arg Met Lys Leu
Arg Met Leu Lys
Arg Pro Phe Lys
Arg Pro Lys Phe
16-Glutaryloxy-1α,25-dihydroxyvitamin D3
16-Glutaryloxy-1α,25-dihydroxy-20-epivitamin D3
Hovenidulcigenin B
Combretic acid C
16-Glutaryloxy-1alpha,25-dihydroxyvitamin D3
16-Glutaryloxy-1alpha,25-dihydroxy-20-epivitamin D3
Phytyl 2-O-methyl-dimethylarsinoylribose
hexanedioic acid,[3-hydroxy-2,2-bis(hydroxymethyl)propyl] (E)-octadec-9-enoate
Xylanase
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C66886 - Nicotinic Antagonist
2-[hydroxy-[(2R)-2-hydroxy-3-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(2R)-2-hydroxy-3-[(5Z,8Z,11Z)-icosa-5,8,11-trienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
3-O-(alpha-L-oleandrosyl)erythronolide B
A macrolide that is erythronolide B having a 2,6-dideoxy-3-O-methyl-alpha-Larabino-hexopyranosyl (alpha-L-oleandrosyl) residue attached at position 3.
(2R)-N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide
(2R)-N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide
(2R)-N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide
(2S)-N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide
(2R)-N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide
(2S)-N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide
1-cyclohexyl-3-[(3R,9R,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
1-cyclohexyl-3-[(3R,9S,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
1-[(3R,9S,10S)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea
1-cyclohexyl-3-[(3S,9R,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
1-[(3S,9S,10S)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea
1-cyclohexyl-3-[(3S,9R,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
1-cyclohexyl-3-[(3S,9R,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
1-cyclohexyl-3-[(3S,9S,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
(2S)-N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide
(2R)-N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide
N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-methyl-3-indolyl)acetamide
1-cyclohexyl-3-[(3R,9R,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
1-[(3R,9S,10R)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea
1-[(3R,9R,10S)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea
1-cyclohexyl-3-[(3S,9S,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
1-[(3R,9R,10R)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea
1-cyclohexyl-3-[(3R,9S,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
1-cyclohexyl-3-[(3R,9S,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
1-cyclohexyl-3-[(3R,9R,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
1-[(3S,9S,10S)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea
1-[(3S,9R,10R)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea
1-[(3R,9R,10R)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea
1-cyclohexyl-3-[(3S,9S,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
1-[(3S,9R,10S)-9-[[cyclopropylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea
1-cyclohexyl-3-[(3R,9S,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
(2S)-N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide
(2S)-N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide
(2R)-N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide
(2R)-N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide
(2S)-N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide
(2S)-N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide
2,3-dihydroxypropyl [3-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoxy]-2-hydroxypropyl] hydrogen phosphate
(2-hydroxy-3-phosphonooxypropyl) (15Z,18Z)-hexacosa-15,18-dienoate
[(4E,8E)-3-hydroxy-2-(pentanoylamino)octadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C28H55N2O6P (546.3797539999999)
[(4E,8E)-2-(butanoylamino)-3-hydroxynonadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C28H55N2O6P (546.3797539999999)
[(E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]non-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C28H55N2O6P (546.3797539999999)
[(4E,8E)-2-(heptanoylamino)-3-hydroxyhexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C28H55N2O6P (546.3797539999999)
[(4E,8E)-2-(hexanoylamino)-3-hydroxyheptadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C28H55N2O6P (546.3797539999999)
[(4E,8E)-2-acetamido-3-hydroxyhenicosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C28H55N2O6P (546.3797539999999)
[(4E,8E)-3-hydroxy-2-(propanoylamino)icosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C28H55N2O6P (546.3797539999999)
[(4E,8E)-3-hydroxy-2-(octanoylamino)pentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C28H55N2O6P (546.3797539999999)
[(4E,8E)-3-hydroxy-2-(nonanoylamino)tetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C28H55N2O6P (546.3797539999999)
[(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C28H55N2O6P (546.3797539999999)
[(4E,8E)-2-(decanoylamino)-3-hydroxytrideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C28H55N2O6P (546.3797539999999)
[(4E,8E)-3-hydroxy-2-(undecanoylamino)dodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C28H55N2O6P (546.3797539999999)
[1-propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-hexadec-9-enoate
[1-acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-heptadec-9-enoate
[1-pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-tetradec-9-enoate
[1-hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-tridec-9-enoate
[1-butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-pentadec-9-enoate
[(E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]oct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C28H55N2O6P (546.3797539999999)
(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate
(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate
(1-hexanoyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate
(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate
(1-octanoyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate
(1-butanoyloxy-3-phosphonooxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate
(1-phosphonooxy-3-propanoyloxypropan-2-yl) (13Z,16Z)-docosa-13,16-dienoate
2-[hydroxy-[(2R)-2-hydroxy-3-[(8E,11E,14E)-icosa-8,11,14-trienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-hydroxy-2-[(4Z,7Z,10Z)-icosa-4,7,10-trienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
[1-carboxy-3-[3-[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
2-[hydroxy-[(2R)-2-hydroxy-3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-propanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-acetyloxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[1-carboxy-3-[3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
2-[hydroxy-[2-hydroxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[2-butanoyloxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
TG(30:4)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
AcHexZyE(0:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
BisMePA(24:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
3-({1-[5-(2-hydroxypropan-2-yl)oxolan-2-yl]-3a,3b,6,6,9a,11a-hexamethyl-dodecahydrocyclopenta[a]phenanthren-7-yl}oxy)-3-oxopropanoic acid
n-{1-[14-(acetyloxy)-6-(dimethylamino)-7,7,12,16-tetramethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2-dien-15-yl]ethyl}benzenecarboximidic acid
(1r,4s,5s,7r,10r,11s,14r,16e,18e,21r,22r,23s,24s)-7,23-dihydroxy-11-isopropyl-4,10,14,16,22,24-hexamethyl-12,25,26-trioxatricyclo[19.3.1.1¹,⁵]hexacosa-2,16,18-triene-9,13-dione
4,8a-dimethyl 2,3,12-trihydroxy-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4,8a-dicarboxylate
undecyl 3-{4-[3-oxo-3-(undecyloxy)propyl]-1,2,3,4-dithiadiazetidin-3-yl}propanoate
4,8a-dimethyl 2,3,12-trihydroxy-4,6a,6b,11,12,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,11,12a,14,14a-tetradecahydropicene-4,8a-dicarboxylate
(2e,4e,6e)-9-{[(2s,3r)-4-{[(3e,5e)-1,7-dihydroxy-4-methylhexadeca-3,5-dien-1-ylidene]amino}-1,3-dihydroxy-2-methylbutylidene]amino}nona-2,4,6-trienoic acid
C31H50N2O6 (546.3668680000001)
methyl (2r,6r)-6-[(1r,3ar,4s,5ar,7s,9as,11s,11ar)-4,7,11-trihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoate
(1s,3as,5ar,7r,9ar,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate
3a,6,6,9a,11a-pentamethyl-4,10-dioxo-1-(5,6,7-trihydroxy-6-methylheptan-2-yl)-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-7-yl acetate
methyl 3-[(3s,3ar,5as,6s,7s,9ar,9br)-3-[(2s,4e,6r)-7-(acetyloxy)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoate
(1s,2r,5s,7s,9r,11s,12s,15r,16s)-15-[(1s)-1-[(2r,4s,5s)-5-(acetyloxy)-4-(2-hydroxypropan-2-yl)oxolan-2-yl]ethyl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadecan-5-yl acetate
(1r,3s,5s,6ar,7s,8s,10r,10as)-1-(acetyloxy)-3-(butanoyloxy)-10-hydroxy-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl (2s)-2-methylbutanoate
methyl 3-[4-(acetyloxy)-3-(2,6-dihydroxy-6-methylhept-4-en-2-yl)-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoate
5-(3,9-dihydroxy-4,6,8,10-tetramethyl-11-oxotridec-6-en-2-yl)-12-ethyl-8,10-dimethyl-4,13-dioxabicyclo[8.2.1]trideca-1(12),7-diene-3,11-dione
4-hydroxy-1-[(7-methoxy-2-oxochromen-8-yl)oxy]-4-methylpentan-3-yl hexadecanoate
1-o-gluco-2-o-gadoleic-glyceride
{"Ingredient_id": "HBIN002914","Ingredient_name": "1-o-gluco-2-o-gadoleic-glyceride","Alias": "NA","Ingredient_formula": "C29H54O9","Ingredient_Smile": "CCCCCCCCCCC=CCCCCCCCC(=O)OC(CO)COC1C(C(C(C(O1)CO)O)O)O","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "8596","TCMSP_id": "NA","TCM_ID_id": "21368","PubChem_id": "NA","DrugBank_id": "NA"}
2alpha,5alpha,10beta-triacetoxy-14beta-(2-methyl)butyryloxytaxa-4(20),11-diene
{"Ingredient_id": "HBIN005241","Ingredient_name": "2alpha,5alpha,10beta-triacetoxy-14beta-(2-methyl)butyryloxytaxa-4(20),11-diene","Alias": "NA","Ingredient_formula": "C31H46O8","Ingredient_Smile": "CCC(C)C(=O)OC1CC(=C2C(CC3(CCC(C(=C)C3C(C1C2(C)C)OC(=O)C)OC(=O)C)C)OC(=O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "32090","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2α,5α,10β-triacetoxy-14β-((s)2-methyl)butyryl-oxytaxa-4(20),11-diene
{"Ingredient_id": "HBIN005244","Ingredient_name": "2\u03b1,5\u03b1,10\u03b2-triacetoxy-14\u03b2-((s)2-methyl)butyryl-oxytaxa-4(20),11-diene","Alias": "NA","Ingredient_formula": "C31H46O8","Ingredient_Smile": "CCC(C)C(=O)OC1CC(=C2C(CC3(CCC(C(=C)C3C(C1C2(C)C)OC(=O)C)OC(=O)C)C)OC(=O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21513","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2alpha-(alpha-methylbutyrul)-oxy-5alpha,7belta,10belta-triacetory-4(20),11-taxadiene
{"Ingredient_id": "HBIN005272","Ingredient_name": "2alpha-(alpha-methylbutyrul)-oxy-5alpha,7belta,10belta-triacetory-4(20),11-taxadiene","Alias": "NA","Ingredient_formula": "C31H46O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25519","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2α-(α-methylbutyryl)-oxy-5α,7β,10β-triacetoxy-4(20),11-taxadiene
{"Ingredient_id": "HBIN005274","Ingredient_name": "2\u03b1-(\u03b1-methylbutyryl)-oxy-5\u03b1,7\u03b2,10\u03b2-triacetoxy-4(20),11-taxadiene","Alias": "NA","Ingredient_formula": "C31H46O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14192","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
acinospesigenin c
{"Ingredient_id": "HBIN014558","Ingredient_name": "acinospesigenin c","Alias": "NA","Ingredient_formula": "C31H46O8","Ingredient_Smile": "CC1(CCC2(CCC3(C(=CC(C4C3(CCC5C4(CC(C(C5(C)C=O)O)O)C)C)O)C2C1)C)C(=O)O)C(=O)OC","Ingredient_weight": "546.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14172","TCMID_id": "548","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "21581817","DrugBank_id": "NA"}
alizexol b
{"Ingredient_id": "HBIN015166","Ingredient_name": "alizexol b","Alias": "NA","Ingredient_formula": "C32H50O7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14234","TCMID_id": "903","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
10-(acetyloxy)-1-(5,6-dimethylhept-3-en-2-yl)-4,7-dihydroxy-9a,11a-dimethyl-5-oxo-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate
(3as,8as)-7-[(3ar,8ar)-1,8-dimethyl-2h,3h,8ah-pyrrolo[2,3-b]indol-3a-yl]-3a-[(3as,8ar)-1,8-dimethyl-2h,3h,8ah-pyrrolo[2,3-b]indol-3a-yl]-1-methyl-2h,3h,8h,8ah-pyrrolo[2,3-b]indole
2,7a-dimethyl (2s,3ar,5ar,5bs,7as,8s,10r,11r,11as,13ar,13br)-2,8,11-trihydroxy-3,3,5a,5b,10,11,13b-heptamethyl-1h,3ah,4h,5h,6h,7h,8h,9h,10h,11ah,13h,13ah-cyclopenta[a]chrysene-2,7a-dicarboxylate
(2s,3r,4r,4ar,6as,6br,8ar,10r,12ar,12br,14br)-10-(acetyloxy)-2,3-dihydroxy-2-(hydroxymethyl)-6a,6b,9,9,12a-pentamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picen-4-yl acetate
(1r)-3,5,5-trimethyl-4-[(3e,5e,7e,9e,11e,13e,15e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)octadeca-3,5,7,9,11,13,15-heptaen-1,17-diyn-1-yl]cyclohex-3-en-1-ol
(1's,2r,2's,4's,7's,8'r,9's,12's,13's,14's,15'r,16'r,18's)-14'-(acetyloxy)-16',18'-dihydroxy-7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-15'-yl acetate
n-[(6s,8r,11r,12s,14r,15s,16r)-14-(acetyloxy)-15-[(1s)-1-(dimethylamino)ethyl]-7,7,12,16-tetramethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2-dien-6-yl]benzenecarboximidic acid
(1s)-3,5,5-trimethyl-4-[(3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,3,6-trimethylphenyl)octadeca-3,5,7,9,11,13,15,17-octaen-1-yn-1-yl]cyclohex-3-en-1-ol
methyl (2s,6r)-6-[(1r,3ar,4s,5ar,7s,9as,11s,11ar)-4,7,11-trihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoate
4-[(3s,4ar,6ar,6bs,9s,10ar,11as,11bs)-3-{[(2r,3r,4r,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-6b-hydroxy-10a,11b-dimethyl-10-methylidene-dodecahydro-1h-cyclohexa[a]fluoren-9-yl]-5h-furan-2-one
(2e,4e,8e)-n-[(1s,2r)-2-hydroxy-1-{[(3z,5s,8s,10s)-2,7,10-trihydroxy-5-methyl-1,6-diazacyclododeca-1,3,6-trien-8-yl]-c-hydroxycarbonimidoyl}propyl]tetradeca-2,4,8-trienimidic acid
3-{[(1r,3as,3br,5ar,7r,9ar,9br,11as)-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)oxolan-2-yl]-3a,3b,6,6,9a,11a-hexamethyl-dodecahydrocyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid
(2s,4ar,6as,6br,8as,9r,10r,11s,12as,12br,14bs)-10,11-dihydroxy-9-(hydroxymethyl)-2-(methoxycarbonyl)-2,6a,6b,9,12a-pentamethyl-13-oxo-3,4,5,6,7,8,8a,10,11,12,12b,14b-dodecahydro-1h-picene-4a-carboxylic acid
(1r,2r,3r,6e,8s,10e,12e,15r,16z,18s,19s)-15-hydroxy-3-[(1e,3r,4s)-4-hydroxy-3-methoxypent-1-en-1-yl]-19-methoxy-2,6,8,10,16-pentamethyl-4,21-dioxabicyclo[16.2.1]henicosa-6,10,12,16-tetraene-5,9-dione
(1s,2s,4s)-4-hydroxy-2-[(6r,7e)-6-hydroxy-10-[(1s,2s)-2-hydroxy-2,6,6-trimethyl-5-oxocyclohex-3-en-1-yl]-3,8-dimethyl-9-oxodeca-3,7-dien-1-yl]-1,3,3-trimethylcyclohexyl acetate
methyl 3-[(3r,3as,4r,5ar,6s,7s,9ar,9br)-4-(acetyloxy)-3-[(2s,4e)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoate
(2e,4e,6e)-9-{[(2s,3r)-4-{[(3e,5e,7s)-1,7-dihydroxy-4-methylhexadeca-3,5-dien-1-ylidene]amino}-1,3-dihydroxy-2-methylbutylidene]amino}nona-2,4,6-trienoic acid
C31H50N2O6 (546.3668680000001)
(1r,3s,5s,6ar,7s,8s,10r,10ar)-1-(acetyloxy)-3-(butanoyloxy)-10-hydroxy-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl 2-methylbutanoate
n-[14-(acetyloxy)-15-[1-(dimethylamino)ethyl]-7,7,12,16-tetramethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),3-dien-6-yl]benzenecarboximidic acid
methyl (2r,6s)-6-[(1s,3ar,4s,5ar,7s,9as,11ar)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-4-oxoheptanoate
5-(acetyloxy)-5-{7-hydroxy-3',9a,11a-trimethyl-tetradecahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-2,3,4-trimethylpentan-2-yl acetate
(2s,4ar,6as,6br,8ar,9s,10r,11s,12as,12br,13r,14br)-9-formyl-10,11,13-trihydroxy-2-(methoxycarbonyl)-2,6a,6b,9,12a-pentamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
5-[2-(acetyloxy)-2-[1-methyl-2-(6-methyl-5-methylideneheptan-2-yl)-5-oxocyclopentyl]ethyl]-2-hydroxy-1,4a-dimethyl-6-oxo-hexahydro-2h-naphthalene-1-carboxylic acid
methyl (2r,6s)-6-[(1r,3ar,4s,5as,7s,9as,11s,11ar)-4,7,11-trihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoate
methyl 3-{3-[7-(acetyloxy)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl}propanoate
n-[14-(acetyloxy)-15-[1-(dimethylamino)ethyl]-7,7,12,16-tetramethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2-dien-6-yl]benzenecarboximidic acid
(1s,2r,3s,4r,7r,9s,12r,14r,16r,17r,18r,19r,21r,22s)-2,9-dihydroxy-22-(2-hydroxypropan-2-yl)-3,8,8,17,19-pentamethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-16-yl acetate
(1r,3r,3as,3bs,7s,9ar,9bs,10r,11ar)-3,10-dihydroxy-1-[(2r,5r)-7-hydroxy-5-isopropylheptan-2-yl]-9a,11a-dimethyl-4-oxo-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl 2-methylpropanoate
2,7a-dimethyl (2s,3ar,5ar,5bs,6s,7as,10r,11r,11as,13ar,13br)-2,6,11-trihydroxy-3,3,5a,5b,10,11,13b-heptamethyl-1h,3ah,4h,5h,6h,7h,8h,9h,10h,11ah,13h,13ah-cyclopenta[a]chrysene-2,7a-dicarboxylate
(1s,3as,5ar,7r,9ar,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate
2-[2-(2-hydroxypropan-2-yl)-5-methoxy-4a,10a-dimethyl-6,9-dioxo-2,3,4,4b,5,11,12,12a-octahydro-1,10-dioxatetraphen-8-yl]-4-methylhexan-3-yl acetate
methyl 2-methyl-4-oxo-6-{4,7,11-trihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}heptanoate
4,8a-dimethyl (2r,3r,4r,4ar,6ar,6bs,8ar,12r,12as,14ar,14br)-2,3,12-trihydroxy-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4,8a-dicarboxylate
1-{12,13-dihydroxy-6,8,14,19,19-pentamethyl-11,23-dioxahexacyclo[18.2.1.0¹,¹⁸.0³,¹⁵.0⁶,¹⁴.0⁷,¹²]tricos-3(15)-en-10-yl}-2-hydroxy-2-methylpropyl acetate
3-({4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl}oxy)-n-heptadecyl-2-hydroxypropanimidic acid
5,9-dihydroxy-2-(2-hydroxypropan-2-yl)-4a,10a-dimethyl-8-(4-methyl-3-oxohexan-2-yl)-9-(2-oxopropyl)-2,3,4,4b,5,11,12,12a-octahydro-1,10-dioxatetraphen-6-one
n-[(1s)-1-[(6s,8s,11r,12s,14r,15s,16r)-14-(acetyloxy)-6-(dimethylamino)-7,7,12,16-tetramethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2-dien-15-yl]ethyl]benzenecarboximidic acid
(2s,3r,4s)-2-[(2r,4ar,4bs,5s,10as,12ar)-2-(2-hydroxypropan-2-yl)-5-methoxy-4a,10a-dimethyl-6,9-dioxo-2,3,4,4b,5,11,12,12a-octahydro-1,10-dioxatetraphen-8-yl]-4-methylhexan-3-yl acetate
(1s,2s,3s,5s,8s,10s,14s)-2,5,10-tris(acetyloxy)-8,12,15,15-tetramethyl-4-methylidenetricyclo[9.3.1.0³,⁸]pentadec-11-en-14-yl (2s)-2-methylbutanoate
(2r)-2-[(1r,2r,3ar,5ar,7s,9as,11ar)-7-(acetyloxy)-2-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methoxy-6-methylheptanoic acid
(1r,2r,3s,4r,7r,9s,12r,14r,16r,17r,18r,19r,21r,22s)-2,9-dihydroxy-22-(2-hydroxypropan-2-yl)-3,8,8,17,19-pentamethyl-24-oxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-16-yl hydrogen carbonate
(1r,2s,3as,3bs,4r,5as,7s,9ar,9bs,10s,11as)-10-(acetyloxy)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-4,7-dihydroxy-9a,11a-dimethyl-5-oxo-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate
7-(acetyloxy)-1-(5,6-dimethylhept-3-en-2-yl)-4,10-dihydroxy-9a,11a-dimethyl-5-oxo-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate
(3e,6r)-6-[(1r,2r,3as,3br,7r,8s,9as,9br,11ar)-2,7,8-trihydroxy-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate
2,9-dihydroxy-22-(2-hydroxypropan-2-yl)-3,8,8,17,19-pentamethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-16-yl acetate
4-{3a-hydroxy-7-[(5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl)oxy]-9a,11a-dimethyl-3h,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-5h-furan-2-one
16-(7,9-dihydroxy-11-methoxy-8,10-dimethyldodec-4-en-2-yl)-8-hydroxy-3,5,7-trimethyl-1-oxacyclohexadeca-3,5,9,13-tetraen-2-one
(2s,4ar,6as,6br,8ar,9s,10r,11s,12as,12br,13r,14bs)-9-formyl-10,11,13-trihydroxy-2-(methoxycarbonyl)-2,6a,6b,9,12a-pentamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
[(2s)-5-oxo-1,4-dioxacyclotricosan-2-yl]methyl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
13-(acetyloxy)-1,7-dihydroxy-6,10,14-trimethyl-15-(6-methyl-5-methylideneheptan-2-yl)-3-oxo-17-oxatetracyclo[12.2.1.0²,¹¹.0⁵,¹⁰]heptadec-2(11)-ene-6-carboxylic acid
9-({4-[(1,7-dihydroxy-4-methylhexadeca-3,5-dien-1-ylidene)amino]-1,3-dihydroxy-2-methylbutylidene}amino)nona-2,4,6-trienoic acid
C31H50N2O6 (546.3668680000001)